StreetInsider.com News Articles

Form 424B5 Alzamend Neuro, Inc.

Fri, 06 Mar 2026 16:46:00 +0000

si-local-file:///var/storage/secattach/20260306/26126220.html

Form 424B5 Alzamend Neuro, Inc.

Fri, 06 Mar 2026 16:46:00 +0000

si-local-file:///var/storage/secattach/20260306/26126220.html

Form 8-K Alzamend Neuro, Inc. For: Mar 06

Fri, 06 Mar 2026 16:31:00 +0000

si-local-file:///var/storage/secattach/20260306/26125966.html

Form 8-K Alzamend Neuro, Inc. For: Mar 06

Fri, 06 Mar 2026 16:31:00 +0000

si-local-file:///var/storage/secattach/20260306/26125966.html

Form DEFA14A Alzamend Neuro, Inc.

Thu, 26 Feb 2026 17:13:00 +0000

si-local-file:///var/storage/secattach/20260226/26072797.html

Form DEFA14A Alzamend Neuro, Inc.

Thu, 26 Feb 2026 17:13:00 +0000

si-local-file:///var/storage/secattach/20260226/26072797.html

Form DEF 14A Alzamend Neuro, Inc. For: Apr 17

Thu, 26 Feb 2026 17:12:00 +0000

si-local-file:///var/storage/secattach/20260226/26072791.html

Form DEF 14A Alzamend Neuro, Inc. For: Apr 17

Thu, 26 Feb 2026 17:12:00 +0000

si-local-file:///var/storage/secattach/20260226/26072791.html

Form PRE 14A Alzamend Neuro, Inc. For: Apr 17

Mon, 09 Feb 2026 16:31:00 +0000

si-local-file:///var/storage/secattach/20260209/25968624.html

Form PRE 14A Alzamend Neuro, Inc. For: Apr 17

Mon, 09 Feb 2026 16:31:00 +0000

si-local-file:///var/storage/secattach/20260209/25968624.html

Form 4 Alzamend Neuro, Inc. For: Dec 23 Filed by: AULT MILTON C III

Tue, 30 Dec 2025 17:54:00 +0000

si-local-file:///var/storage/secattach/20251230/25791855.html

Form 4 Alzamend Neuro, Inc. For: Dec 23 Filed by: AULT MILTON C III

Tue, 30 Dec 2025 17:54:00 +0000

si-local-file:///var/storage/secattach/20251230/25791855.html

Form 4 Alzamend Neuro, Inc. For: Dec 19 Filed by: Horne William B.

Tue, 23 Dec 2025 16:30:00 +0000

si-local-file:///var/storage/secattach/20251223/25777456.html

Form 4 Alzamend Neuro, Inc. For: Dec 19 Filed by: Horne William B.

Tue, 23 Dec 2025 16:30:00 +0000

si-local-file:///var/storage/secattach/20251223/25777456.html

Form 10-Q Alzamend Neuro, Inc. For: Oct 31

Tue, 09 Dec 2025 16:31:00 +0000

si-local-file:///var/storage/secattach/20251209/25718731.html

Form 10-Q Alzamend Neuro, Inc. For: Oct 31

Tue, 09 Dec 2025 16:31:00 +0000

si-local-file:///var/storage/secattach/20251209/25718731.html

Alzamend Neuro completes Phase II clinical trial of AL001 lithium therapy

Wed, 19 Nov 2025 08:01:45 +0000

Alzamend Neuro, Inc. (NASDAQ: ALZN) announced completion of the clinical portion of its Phase II clinical trial of AL001, a lithium-delivery system designed for treating neurological and psychiatric disorders. The study was conducted at Massachusetts General Hospital in healthy human subjects.

The trial compared AL001 against a marketed lithium carbonate product to evaluate lithium distribution in blood and brain structures. The study utilized a specialized head coil developed by Tesla Dynamic Coils BV for high-resolution brain lithium imaging, allowing precise measurement of lithium within specific brain regions.

Topline data from the completed study is expected in the first quarter of 2026, according

Alzamend Neuro completes Phase II clinical trial of AL001 lithium therapy

Wed, 19 Nov 2025 08:01:45 +0000

Topline data from the completed study is expected in the first quarter of 2026, according

Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital

Wed, 19 Nov 2025 08:00:00 +0000

Topline data expected in first quarter of 2026

Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital

Wed, 19 Nov 2025 08:00:00 +0000

Topline data expected in first quarter of 2026

Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital

Wed, 19 Nov 2025 08:00:00 +0000

Topline data expected in first quarter of 2026

Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital

Wed, 19 Nov 2025 08:00:00 +0000

Topline data expected in first quarter of 2026

Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital

Wed, 19 Nov 2025 08:00:00 +0000

Topline data expected in first quarter of 2026

Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital

Wed, 19 Nov 2025 08:00:00 +0000

Topline data expected in first quarter of 2026

Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital

Wed, 19 Nov 2025 08:00:00 +0000

Topline data expected in first quarter of 2026